# Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.

> **NCT00335725** · PHASE3 · COMPLETED · sponsor: **IBSA Institut Biochimique SA** · enrollment: 151 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Follicle Stimulating Hormone
- **DRUG:** Follicle Stimulating Hormone

## Key facts

- **NCT ID:** NCT00335725
- **Lead sponsor:** IBSA Institut Biochimique SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2015-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335725, "Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00335725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*